A 58-year-old man with long-standing type 2 diabetes and hypertension presents with progressive bilateral leg swelling, frothy urine and eGFR 35 mL/min/1.73 m². Urine ACR is markedly elevated. Which additional measure is most appropriate to reduce his risk of kidney disease progression and cardiovascular events?